Diego Medina-Marquez
Zaragoza, AR, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Opening Windows for Thymic Tumors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 25, 2022
PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis.
Journal: Journal of clinical medicine
Published: February 18, 2021
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 31, 2019
Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 11, 2018
Massive Hemoptysis after the First Administration of Pembrolizumab in a Strongly Positive, Centrally Located NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 29, 2017
Increase in neoplastic disease in patients with chronic obstructive pulmonary disease. Two not so unrelated entities.
Journal: Revista clinica espanola
Published: August 30, 2017
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 30, 2017
Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: February 02, 2016
Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 03, 2015
Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: August 29, 2015
Systemic therapy for pulmonary carcinoids.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 24, 2015
Last Updated: 09/26/2026